| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
2000-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ffe1272553482517eef66979826cf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_938c48e8ce1c8ee927be2f3e1c16a9fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c403c585323f8b9bd71107ef08c7715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c21493b205529ef6dae97e0fb081ead |
| publicationDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1189907-B1 |
| titleOfInvention |
Thienopyrimidines as phosphodiesterase inhibitors |
| abstract |
The invention relates to the thienopyrimidines of formula (I) and their physiologically acceptable salts, wherein R1, R2 and X have the definitions indicated in claim 1. The inventive substances are characterized by a phosphodiesterase V inhibition and are used for the treatment of cardiovascular diseases and for the treatment and/or therapy of impaired potency. |
| priorityDate |
1999-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |